{"doi":"10.3201/eid2603.191018","title":"Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola","abstract":"Little information exists regarding Ebola vaccine rVSVΔG-ZEBOV-GP and pregnancy. The Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE) randomized participants without blinding to immediate or deferred (18-24 weeks postenrollment) vaccination. Pregnancy was an exclusion criterion, but 84 women were inadvertently vaccinated in early pregnancy or became pregnant <60 days after vaccination or enrollment. Among immediate vaccinated women, 45% (14/31) reported pregnancy loss, compared with 33% (11/33) of unvaccinated women with contemporaneous pregnancies (relative risk 1.35, 95% CI 0.73-2.52). Pregnancy loss was similar among women with higher risk for vaccine viremia (conception before or <14 days after vaccination) (44% [4/9]) and women with lower risk (conception >15 days after vaccination) (45% [10/22]). No congenital anomalies were detected among 44 live-born infants examined. These data highlight the need for Ebola vaccination decisions to balance the possible risk for an adverse pregnancy outcome with the risk for Ebola exposure.","journal":"Emerging infectious diseases","year":2020,"id":96949,"datarank":1.5631359029869576,"base_score":3.5263605246161616,"endowment":3.5263605246161616,"self_citation_contribution":0.5289540786924243,"citation_network_contribution":1.0341818242945333,"self_endowment_contribution":0.5289540786924243,"citer_contribution":1.0341818242945333,"corpus_percentile":null,"corpus_rank":null,"citation_count":33,"citer_count":33,"citers_with_citation_signal":30,"citers_with_endowment":30,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9529,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT02378753"],"PACTR":["PACTR201502001037220"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":387491,"name":"Rosalind J. Carter","orcid":"0000-0003-2917-5827","position":1,"is_corresponding":false},{"id":480330,"name":"Susan T. Goldstein","orcid":null,"position":2,"is_corresponding":false},{"id":479791,"name":"Olamide D. Jarrett","orcid":"0000-0001-7662-3771","position":3,"is_corresponding":false},{"id":480331,"name":"Elena Szefer","orcid":null,"position":4,"is_corresponding":false},{"id":479792,"name":"Augustin E Fombah","orcid":"0000-0002-2905-5414","position":5,"is_corresponding":false},{"id":312582,"name":"Sarah C. Tinker","orcid":"0000-0002-7610-6288","position":6,"is_corresponding":false},{"id":479793,"name":"Mohamed Samai","orcid":"0000-0002-1427-9482","position":7,"is_corresponding":false},{"id":480332,"name":"Barbara E. Mahon","orcid":null,"position":8,"is_corresponding":false},{"id":480329,"name":"Jennifer Legardy-Williams","orcid":null,"position":0,"is_corresponding":true}],"reference_count":33,"raw_metadata":null,"created_at":"2026-07-18T22:35:06.014648Z","pmid":"32017677","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}